A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study, to Assess Efficacy, Safety and Immunogenicity of JNJ-64042056, a Phosphorylated Tau Targeted Active Immunotherapy, in Participants With Preclinical Alzheimer's Disease
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study, to Assess Efficacy, Safety and Immunogenicity of JNJ-64042056, a Phosphorylated Tau Targeted Active Immunotherapy, in Participants With Preclinical Alzheimer's Disease
The purpose of this study is to assess whether JNJ-64042056 affects the spread and build up of tau (a protein in brain) when compared with placebo, using brain scan (tau PET) to determine results from specific areas of the brain.
Inclusion Criteria:
Exclusion Criteria:
Chofu-shi, 1820036, Japan
Hirakata-shi, 573-1121, Japan
Narashino-shi, 275-8580, Japan
Shinjuku Ku, 160 0008, Japan
Shinjuku-ku, 169-0072, Japan
Shinjyuku Ku, 160 0017, Japan
Suita Shi, 565 0853, Japan
Toyonaka-shi, 560-0004, Japan
Toyonaka-shi, 5600004, Japan